š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Primary Objective: To evaluate for each influenza strain the non-inferiori...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00391391
To describe any degree of preference for the route of administration of Flu...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00623181
Treatments Being Tested
This study is designed to assess the immunogenicity and safety of the 2010-...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01215669
The purpose of this research study is to find out if giving the smaller dos...
Status
Completed
Location
Saint Louis University
Start Date
2005-11
Trial ID
NCT00253734
Treatments Being Tested
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691339
The aim of the study is to evaluate the safety and immunogenicity of the 20...
Status
Completed
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02563093
A new flu vaccine which is injected into the skin instead of into the muscl...
Status
Completed
Location
National Jewish Health
Start Date
2011-11
Trial ID
NCT01518478
Treatments Being Tested
The purpose of this study is to investigate the responses to licensed triva...
Status
Completed
Location
Stanford LPCH Vaccine Program
Start Date
2011-08
Trial ID
NCT02141581
Treatments Being Tested
The purpose of this study is to generate additional data on the immunogenic...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT01011049
This is a multi-center study designed to evaluate the safety and immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00775450